# Feasibility Pilot for the ReBOO-trial

> **NCT03079557** · PHASE2 · COMPLETED · sponsor: **St. Olavs Hospital** · enrollment: 10 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Intragastric botulinum toxin type A

## Key facts

- **NCT ID:** NCT03079557
- **Lead sponsor:** St. Olavs Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-14
- **Primary completion:** 2019-04-30
- **Final completion:** 2019-04-30
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2020-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03079557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03079557, "Feasibility Pilot for the ReBOO-trial". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03079557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*